中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2015年
1期
30-30,31
,共2页
诱导化疗%同期放化疗%鼻咽癌%疗效
誘導化療%同期放化療%鼻嚥癌%療效
유도화료%동기방화료%비인암%료효
Induction chemotherapy%Concurrent chemoradiotherapy%Nasopharyngeal carcinoma%Ccurative effect
目的:研究分析TPF方案诱导化疗联合同期放化疗治疗中晚期鼻咽癌的近期疗效。方法选取我院2012年4月至2013年4月收治的78例中晚期鼻咽癌患者,随机将其分成对照组与研究组两组,给予对照组采用PF方案同期放化疗,给予研究组在对照组的基础上加用TPF方案诱导化疗2周期,比较两组近期疗效。结果研究组治疗有效率分别为87.2%、82.1%,明显高于对照组的59.0%、53.8%,有统计学意义(P<0.05),研究组患者的血液毒性发生率高于对照组(P<0.05)。结论诱导化疗联合放疗治疗中晚期鼻咽癌,近期疗效佳,耐受性较好。
目的:研究分析TPF方案誘導化療聯閤同期放化療治療中晚期鼻嚥癌的近期療效。方法選取我院2012年4月至2013年4月收治的78例中晚期鼻嚥癌患者,隨機將其分成對照組與研究組兩組,給予對照組採用PF方案同期放化療,給予研究組在對照組的基礎上加用TPF方案誘導化療2週期,比較兩組近期療效。結果研究組治療有效率分彆為87.2%、82.1%,明顯高于對照組的59.0%、53.8%,有統計學意義(P<0.05),研究組患者的血液毒性髮生率高于對照組(P<0.05)。結論誘導化療聯閤放療治療中晚期鼻嚥癌,近期療效佳,耐受性較好。
목적:연구분석TPF방안유도화료연합동기방화료치료중만기비인암적근기료효。방법선취아원2012년4월지2013년4월수치적78례중만기비인암환자,수궤장기분성대조조여연구조량조,급여대조조채용PF방안동기방화료,급여연구조재대조조적기출상가용TPF방안유도화료2주기,비교량조근기료효。결과연구조치료유효솔분별위87.2%、82.1%,명현고우대조조적59.0%、53.8%,유통계학의의(P<0.05),연구조환자적혈액독성발생솔고우대조조(P<0.05)。결론유도화료연합방료치료중만기비인암,근기료효가,내수성교호。
ObjectiveTo study the Short-term therapeutic effect for induction chemotherapy and concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma.Methods From April 2012 and April 2013,78 patients with nasopharyngeal carcinoma(NPC) middle-late period, randomly divided into control group and the team will be two groups, control group only with concurrent chemoradiotherapy treatment, giving the team in the control group with induction chemotherapy method.Results Treatment group effectiveness were 87.2%, 87.2%, significantly higher than the control group were 59.0%, 53.8%, obvious difference compared the two groups was statistically significant(P<0.05).Conclusion Induction chemotherapy combined radiotherapy treating middle-late nasopharyngeal carcinoma, the recent curative effect good.